Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Lung Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01266135
What this trial is testing

Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 40
Not applicableUnknownNCT03229343
What this trial is testing

Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis.

Who this might be right for
Idiopathic Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 120
Large-scale testing (Phase 3)Study completedNCT00662038
What this trial is testing

Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc. 1,058
Not applicableLooking for participantsNCT03297775
What this trial is testing

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
University of Colorado, Denver 750
Not applicableStudy completedNCT01874223
What this trial is testing

Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Stanford University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06567717
What this trial is testing

Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Cedars-Sinai Medical Center 60
Testing effectiveness (Phase 2)WithdrawnNCT05349760
What this trial is testing

Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
IPF
AmMax Bio, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00690885
What this trial is testing

Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Disease, Chronic ObstructivePulmonary FibrosisCough
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 1
Testing effectiveness (Phase 2)Study completedNCT02707640
What this trial is testing

Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 123
Not applicableLooking for participantsNCT07312305
What this trial is testing

Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisSmall Airways Disease
University of Milan 100
Not applicableLooking for participantsNCT00258570
What this trial is testing

Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Pulmonary Fibrosis
University of Pittsburgh 2,000
Very early researchActive Not RecruitingNCT05365802
What this trial is testing

FAPI PET for Lung Fibrosis

Who this might be right for
Interstitial Lung DiseaseIdiopathic Interstitial PneumoniasDrug-Induced Pneumonitis+4 more
University of California, Los Angeles 30
Not applicableLooking for participantsNCT06323876
What this trial is testing

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Virginia 160
Not applicableStudy completedNCT04031690
What this trial is testing

Health and Quality of Life Assessment Project for Caregivers of Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Idiopathic Pulmonary FibrosisPatient-caregiver Dyads
Centre Hospitalier Universitaire Dijon 151
Not applicableStudy completedNCT03268915
What this trial is testing

Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Grenoble 35
Large-scale testing (Phase 3)Ended earlyNCT01777737
What this trial is testing

Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole

Who this might be right for
Idiopathic Pulmonary Fibrosis
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 3
Large-scale testing (Phase 3)Ended earlyNCT03711162
What this trial is testing

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

Who this might be right for
Idiopathic Pulmonary Fibrosis
Lakefront Biotherapeutics NV 525
Not applicableStudy completedNCT03261037
What this trial is testing

Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung Disease
Hoffmann-La Roche 178
Testing effectiveness (Phase 2)Study completedNCT02738801
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Lakefront Biotherapeutics NV 23
Large-scale testing (Phase 3)Looking for participantsNCT05674994
What this trial is testing

Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Who this might be right for
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Fondation Hôpital Saint-Joseph 110
Next Page